Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
作者： James T. Dalton , Sunjoo Ahn , Ramesh Narayanan , Mitchell S. Steiner
DOI:
关键词:
摘要: This invention relates to the treatment of breast cancer in a subject, for example female subject. Including methods of: treating metastatic cancer; refractory AR-positive and ER-positive triple negative advanced that has failed SERM (tamoxifen, toremifene), aromatase inhibitor, palbociclib (Ibrance), trastuzumab (Herceptin, ado-trastuzumab emtansine), pertuzumab (Perjeta), lapatinib, exemestane (Aromasin), bevacizumab (Avastin), and/or fulvestrant treatments; metastasis subject suffering from HER2-positive; comprising administering therapeutically effective amount selective androgen receptor modulator (SARM) compound.
lens.org参考文章(296)
Kalyan Sundaram, Narender Kumar, C. Wayne Bardin, 7 alpha-methyl-nortestosterone (MENT): the optimal androgen for male contraception. Annals of Medicine. ,vol. 25, pp. 199- 205 ,(1993) , 10.3109/07853899309164168
Robert I. Higuchi, James P. Edwards, Thomas R. Caferro, Josef D. Ringgenberg, James W. Kong, Lawrence G. Hamann, Kristen L. Arienti, Keith B. Marschke, Robert L. Davis, Luc J. Farmer, Todd K. Jones, 4-Alkyl- and 3,4-dialkyl-1,2,3,4-tetrahydro-8-pyridono[5,6-g]quinolines: potent, nonsteroidal androgen receptor agonists. Bioorganic & Medicinal Chemistry Letters. ,vol. 9, pp. 1335- 1340 ,(1999) , 10.1016/S0960-894X(99)00186-9
Dike N. Kalu, The ovariectomized rat model of postmenopausal bone loss Bone and Mineral. ,vol. 15, pp. 175- 191 ,(1991) , 10.1016/0169-6009(91)90124-I
Muthulekha Swamydas, Krista Ricci, Stephen L. Rego, Didier Dréau, Mesenchymal stem cell-derived CCL-9 and CCL-5 promote mammary tumor cell invasion and the activation of matrix metalloproteinases Cell Adhesion & Migration. ,vol. 7, pp. 315- 324 ,(2013) , 10.4161/CAM.25138
Jeffrey D. Kearbey, Wenqing Gao, Ramesh Narayanan, Scott J. Fisher, Di Wu, Duane D. Miller, James T. Dalton, Selective Androgen Receptor Modulator (SARM) Treatment Prevents Bone Loss and Reduces Body Fat in Ovariectomized Rats Pharmaceutical Research. ,vol. 24, pp. 328- 335 ,(2007) , 10.1007/S11095-006-9152-9
Kazuyuki Furuya, Noriko Yamamoto, Yuki Ohyabu, Akito Makino, Teruyuki Morikyu, Hirohide Ishige, Kazuya Kuzutani, Yasuhisa Endo, The Novel Non-steroidal Selective Androgen Receptor Modulator S-101479 Has Additive Effects with Bisphosphonate, Selective Estrogen Receptor Modulator, and Parathyroid Hormone on the Bones of Osteoporotic Female Rats Biological & Pharmaceutical Bulletin. ,vol. 35, pp. 1096- 1104 ,(2012) , 10.1248/BPB.B12-00054
Ramesh Narayanan, Christopher C. Coss, Muralimohan Yepuru, Jeffrey D. Kearbey, Duane D. Miller, James T. Dalton, Steroidal androgens and nonsteroidal, tissue-selective androgen receptor modulator, S-22, regulate androgen receptor function through distinct genomic and nongenomic signaling pathways. Molecular Endocrinology. ,vol. 22, pp. 2448- 2465 ,(2008) , 10.1210/ME.2008-0160
Wenqing Gao, James T. Dalton, Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs). Drug Discovery Today. ,vol. 12, pp. 241- 248 ,(2007) , 10.1016/J.DRUDIS.2007.01.003
Z X Zhou, M V Lane, J A Kemppainen, F S French, E M Wilson, Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. Molecular Endocrinology. ,vol. 9, pp. 208- 218 ,(1995) , 10.1210/MEND.9.2.7776971
Donghua Yin, Yali He, Minoli A. Perera, Seoung Soo Hong, Craig Marhefka, Nina Stourman, Leonid Kirkovsky, Duane D. Miller, James T. Dalton, Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor. Molecular Pharmacology. ,vol. 63, pp. 211- 223 ,(2003) , 10.1124/MOL.63.1.211